 Testicular Neoplasms
"Testicular Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the TESTIS. Germ cell tumors (GERMINOMA) of the testis constitute 95% of all testicular neoplasms.
| Descriptor ID |
D013736
|
| MeSH Number(s) |
C04.588.322.762 C04.588.945.440.915 C12.294.260.937 C12.758.409.937 C19.344.762 C19.391.829.782
|
| Concept/Terms |
Testicular Neoplasms- Testicular Neoplasms
- Neoplasm, Testicular
- Testicular Neoplasm
- Testicular Tumors
- Testis Neoplasms
- Neoplasms, Testicular
- Neoplasms, Testis
- Neoplasm, Testis
- Testis Neoplasm
Tumor of Rete Testis- Tumor of Rete Testis
- Rete Testis Tumor
- Rete Testis Tumors
- Testis Tumor, Rete
- Testis Tumors, Rete
Cancer of Testis- Cancer of Testis
- Testis Cancers
- Testis Cancer
- Cancer, Testis
- Cancers, Testis
- Cancer of the Testes
- Cancer of the Testis
- Testicular Cancer
- Cancer, Testicular
- Cancers, Testicular
- Testicular Cancers
|
Below are MeSH descriptors whose meaning is more general than "Testicular Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Testicular Neoplasms".
This graph shows the total number of publications written about "Testicular Neoplasms" by people in UAMS Profiles by year, and whether "Testicular Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 2 | 1 | 3 | | 2022 | 1 | 0 | 1 | | 2021 | 1 | 0 | 1 | | 2020 | 2 | 0 | 2 | | 2019 | 1 | 0 | 1 | | 2018 | 4 | 0 | 4 | | 2017 | 2 | 0 | 2 | | 2016 | 6 | 0 | 6 | | 2015 | 2 | 0 | 2 | | 2014 | 1 | 0 | 1 | | 2013 | 2 | 0 | 2 | | 2012 | 1 | 0 | 1 | | 2010 | 2 | 0 | 2 | | 2009 | 2 | 0 | 2 | | 2007 | 5 | 0 | 5 | | 2006 | 2 | 0 | 2 | | 2005 | 1 | 0 | 1 | | 2004 | 2 | 2 | 4 | | 2003 | 3 | 0 | 3 | | 2002 | 1 | 0 | 1 | | 2001 | 1 | 0 | 1 | | 1994 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Testicular Neoplasms" by people in Profiles over the past ten years.
-
Tabet GC, Zheng L, Hosseini H, Ward J, Pisters L, Campbell MT, Tu SM, Czerniak B, Guo CC. Epithelioid trophoblastic tumor in male patients with germ cell tumor: A clinicopathologic analysis of five cases. Hum Pathol. 2024 Nov; 153:105673.
-
Abdulfatah E, Brown NA, Davenport MS, Reichert ZR, Camelo-Piragua S, Heider A, Huang T, Vaishampayan UN, Skala SL, Montgomery JS, Chinnaiyan AM, Kaffenberger SD, Bawa P, Shao L, Mehra R. Extragonadal germ cell tumors: A clinicopathologic study with emphasis on molecular features, clinical outcomes and associated secondary malignancies. Hum Pathol. 2024 06; 148:41-50.
-
Dinh PC, Monahan PO, Foss? SD, Sesso HD, Feldman DR, Dolan ME, Nevel K, Kincaid J, Vaughn DJ, Martin NE, Sanchez VA, Einhorn LH, Frisina R, Fung C, Kroenke K, Travis LB. Impact of pain and adverse health outcomes on long-term US testicular cancer survivors. J Natl Cancer Inst. 2024 Mar 07; 116(3):455-467.
-
Hwang MJ, Hamza A, Zhang M, Tu SM, Pisters LL, Czerniak B, Guo CC. Somatic-type Malignancies in Testicular Germ Cell Tumors: A Clinicopathologic Study of 63 Cases. Am J Surg Pathol. 2022 01 01; 46(1):11-17.
-
Hajiran A, Azizi M, Aydin AM, Chakiryan NH, Peyton CC, Boulware DC, Manley BJ, Gilbert SM, Sexton WJ. Retroperitoneal Lymph Node Dissection Versus Surveillance for Adult Early Stage Pure Testicular Teratoma: A Nationwide Analysis. Ann Surg Oncol. 2021 Jul; 28(7):3648-3655.
-
Chertack N, Ghandour RA, Singla N, Freifeld Y, Hutchinson RC, Courtney K, Bowman IA, Arafat W, Meng X, Moore JA, Aydin AM, Sagalowsky AI, Margulis V, Lotan Y, Woldu SL, Bagrodia A. Overcoming sociodemographic factors in the care of patients with testicular cancer at a safety net hospital. Cancer. 2020 10 01; 126(19):4362-4370.
-
El Jamal SM, Salama A, Marcellino BK, Abulsayen HA, Zhou X, Hassan M, Firpo-Betancourt A, Saad AG. Myeloid Sarcoma of the Testis in Children: Clinicopathologic and Immunohistochemical Characteristics With KMT2A (MLL) Gene Rearrangement Correlation. Appl Immunohistochem Mol Morphol. 2020 08; 28(7):501-507.
-
Kamel MH, Khalil MI, Eltahawy E, Davis R, Bissada NK. Organ-sparing procedures in GU cancer: part 2-organ-sparing procedures in testicular and penile tumors. Int Urol Nephrol. 2019 Oct; 51(10):1699-1708.
-
Woldu SL, Moore JA, Ci B, Freifeld Y, Clinton TN, Aydin AM, Singla N, Laura-Maria K, Hutchinson RC, Amatruda JF, Sagalowsky A, Lotan Y, Arriaga Y, Margulis V, Xie Y, Bagrodia A. Practice Patterns and Impact of Postchemotherapy Retroperitoneal Lymph Node Dissection on Testicular Cancer Outcomes. Eur Urol Oncol. 2018 08; 1(3):242-251.
-
Chahoud J, Zhang M, Pisters LL, Lin SC, Lin SH, Tu SM. Identification of Glypican-3 (GPC3) Expression in a Lethal Subgroup of Refractory Cisplatin-Resistant Testicular Germ-Cell Tumors. Clin Genitourin Cancer. 2018 10; 16(5):325-327.
-
Chahoud J, Zhang M, Shah A, Lin SH, Pisters LL, Tu SM. Managing seminomatous and nonseminomatous germ cell tumors. Curr Opin Oncol. 2018 05; 30(3):181-188.
-
Spratt DE, Suresh K, Osawa T, Schipper M, Jackson WC, Abugharib A, Lebastchi A, Smith D, Montgomery JS, Palapattu GS, Priya Kunju L, Wu A, Lew M, Tomlins SA, Chinnaiyan AM, Weizer AZ, Hafez KS, Kaffenberger SD, Udager A, Mehra R. Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissections. Med Oncol. 2018 Jan 31; 35(3):21.
-
Woldu SL, Aydin AM, Rao AV, Hutchinson RC, Singla N, Clinton TN, Krabbe LM, Passoni NM, Raj GV, Miller DS, Amatruda JF, Sagalowsky AI, Lotan Y, Arriaga Y, Margulis V, Bagrodia A. Differences at Presentation and Treatment of Testicular Cancer in Hispanic Men: Institutional and National Hospital-based Analyses. Urology. 2018 02; 112:103-111.
-
George N, Perisetti A, Raghavapuram S, Banerjee D, Kuo E, Tharian B. Metastatic duodenal germ cell tumor diagnosed with endoscopic ultrasound. Endoscopy. 2018 01; 50(1):E27-E28.
-
Bilen MA, Hess KR, Campbell MT, Wang J, Broaddus RR, Karam JA, Ward JF, Wood CG, Choi SL, Rao P, Zhang M, Naing A, General R, Cauley DH, Lin SH, Logothetis CJ, Pisters LL, Tu SM. Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis. Oncotarget. 2016 Dec 27; 7(52):86280-86289.
-
Hao L, Mahmoud F. Image Diagnosis: A Striking Bleomycin-Induced Skin Toxicity: Flagellate Hyperpigmentation. Perm J. 2017; 21:16-001.
-
Pearce SM, Golan S, Gorin MA, Luckenbaugh AN, Williams SB, Ward JF, Montgomery JS, Hafez KS, Weizer AZ, Pierorazio PM, Allaf ME, Eggener SE. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer. Eur Urol. 2017 03; 71(3):476-482.
-
Tu SM, Bilen MA, Hess KR, Broaddus RR, Kopetz S, Wei C, Pagliaro LC, Karam JA, Ward JF, Wood CG, Rao P, Tu ZH, General R, Chen AH, Nieto YL, Yeung SC, Lin SH, Logothetis CJ, Pisters LL. Intratumoral heterogeneity: Role of differentiation in a potentially lethal phenotype of testicular cancer. Cancer. 2016 06 15; 122(12):1836-43.
-
Kamel MH, Littlejohn N, Cox M, Eltahawy EA, Davis R. Post-Chemotherapy Robotic Retroperitoneal Lymph Node Dissection: Institutional Experience. J Endourol. 2016 05; 30(5):510-9.
-
Kamel MH, Davis R. Author Reply. Urology. 2016 Jan; 87:145.
-
Kamel MH, Elfaramawi M, Jadhav S, Saafan A, Raheem OA, Davis R. Insurance Status and Differences in Treatment and Survival of Testicular Cancer Patients. Urology. 2016 Jan; 87:140-5.
-
Lange JH, Cegolon L. Non-asbestos Causes of mesothelioma and translocation of asbestos fibres. Singapore Med J. 2015 Jun; 56(6):361.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|